Publication ListDopamine

 

 

  • Mayer, F.P., Schmid, D., Owens, W.A., Gould, G.G., Apuschkin, M., Kudlacek, O., Salzer, I., Boehm, S., Chiba, P., Williams, P.H., Wu, H.H., Gether, U., Koek, W., Daws, L.C., Sitte, H.H.An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacol., 2018, 43(12):2408-2417 https://www.ncbi.nlm.nih.gov/pubmed/29773909.

  • Thakur, P., Breger, L.S., Lundblad, M., Wan, O.W., Mattsson, B., Luk, K.C., Lee, V.M.Y., Trojanowski, J.Q., Björklund, A. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proc. Natl. Acad. Sci. USA., 2017, 114(39):E8284-93 https://www.ncbi.nlm.nih.gov/pubmed/28900002.

  • Womersley, J.S., Kellaway, L.A., Stein, D.J., Gerhardt, G.A., Russell, V.A. Effect of cocaine on striatal dopamine clearance in a rat model of developmental stress and attention-deficit/hyperactivity disorder. Stress, 2016. 19(1):78-82. https://www.ncbi.nlm.nih.gov/pubmed/26394534.

  • Aldrin-Kirk, P., Heuer, A., Wang, G., Mattsson, B., Lundblad, M., Parmar, M., Björklund, T. DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor. Neuron, 2016, 90(5):955-68. https://www.ncbi.nlm.nih.gov/pubmed/26394534.

  • Larhammar, M., Patra, K., Blunder, M., Emilsson, L., Peuckert, C., Arvidsson, E., Ronnlund, D., Preobraschenski, J., Birgner, C., Limbach, C., Widengren, J., Blom, H., Jahn, R., Wallen-Mackenzie, A. and Kullander, K. SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis. Biological psychiatry, 2015, 77(6):526-36. http://www.ncbi.nlm.nih.gov/pubmed/25176177.

  • Baladi, M.G., Horton, R.E., Owens, W.A., Daws, L.C. and France, C.P. Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum, 2015, 18(7): http://www.ncbi.nlm.nih.gov/pubmed/25805560

  • Nordstrom, U., Beauvais, G., Ghosh, A., Pulikkaparambil Sasidharan, B.C., Lundblad, M., Fuchs, J., Joshi, R.L., Lipton, J.W., Roholt, A., Medicetty, S., Feinstein, T.N., Steiner, J.A., Escobar Galvis, M.L., Prochiantz, A. and Brundin, P. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Neurobiol Dis, 2014, 73C(70-82. http://www.ncbi.nlm.nih.gov/pubmed/25281317.

  • Arvidsson, E., et al. Age- and sex-dependence of dopamine release and capacity for recovery identified in the dorsal striatum of C57/Bl6J mice. PloS one, 2014, 9(6):e99592. http://www.ncbi.nlm.nih.gov/pubmed/24925086.

  • Larhammar, M., et al. SLC10A4 Is a Vesicular Amine-Associated Transporter Modulating Dopamine Homeostasis. Biological psychiatry, 2014, 10.1016/j.biopsych.2014.07.017 http://www.ncbi.nlm.nih.gov/pubmed/25176177.

  • Nevalainen, N., et al. Serotonergic nerve fibers in L-DOPA-derived dopamine release and dyskinesia. Neuroscience, 2014, 260(73-86. http://www.ncbi.nlm.nih.gov/pubmed/24361918.

  • Decressac, M., et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(19):E1817-26. http://www.ncbi.nlm.nih.gov/pubmed/23610405.

  • Garcia-Olivares, J., et al. Inhibition of dopamine transporter activity by G protein betagamma subunits. PloS one, 2013, 8(3):e59788. http://www.ncbi.nlm.nih.gov/pubmed/23555781.

  • Laplante, F., et al. Reduction in cholinergic interneuron density in the nucleus accumbens attenuates local extracellular dopamine release in response to stress or amphetamine. Synapse, 2013, 67(1):21-9. http://www.ncbi.nlm.nih.gov/pubmed/23034725.

  • Naef, L., et al. Reduced anticipatory dopamine responses to food in rats exposed to high fat during early development. International journal of obesity, 2013, 37(6):885-8. http://www.ncbi.nlm.nih.gov/pubmed/22964789.

  • Rickhag, M., et al. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. The Journal of biological chemistry, 2013, 288(38):27534-44. http://www.ncbi.nlm.nih.gov/pubmed/23884410.

  • Kirkeby, A., et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell reports, 2012, 1(6):703-14. http://www.ncbi.nlm.nih.gov/pubmed/22813745.

  • Laplante, F., et al. Cholinergic depletion in nucleus accumbens impairs mesocortical dopamine activation and cognitive function in rats. Neuropharmacology, 2012, 63(6):1075-84. http://www.ncbi.nlm.nih.gov/pubmed/22842071.

  • Littrell, O.M., et al. Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiology of aging, 2012, 33(2):427 e1-14. http://www.ncbi.nlm.nih.gov/pubmed/21144620.

  • Lundblad, M., et al. Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(9):3213-9. http://www.ncbi.nlm.nih.gov/pubmed/22315428.

  • Miller, E.M., et al. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens. Neuropharmacology, 2012, 63(8):1327-34. http://www.ncbi.nlm.nih.gov/pubmed/22960443.

  • Alsio, J., et al. Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, 31(35):12593-603. http://www.ncbi.nlm.nih.gov/pubmed/21880920.

  • Larsen, M.B., et al. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, 31(17):6605-15. http://www.ncbi.nlm.nih.gov/pubmed/21525301.

  • Morris, J.K., et al. Insulin resistance impairs nigrostriatal dopamine function. Experimental neurology, 2011, 231(1):171-80. http://www.ncbi.nlm.nih.gov/pubmed/21703262.

  • Nevalainen, N., et al. Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. Journal of neurochemistry, 2011, 118(1):12-23. http://www.ncbi.nlm.nih.gov/pubmed/21534956.

  • Speed, N., et al. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PloS one, 2011, 6(9):e25169. http://www.ncbi.nlm.nih.gov/pubmed/21969871.

  • Womersley, J.S., et al. Maternal separation affects dopamine transporter function in the spontaneously hypertensive rat: an in vivo electrochemical study. Behavioral and brain functions : BBF, 2011, 7(49. http://www.ncbi.nlm.nih.gov/pubmed/22133315.

  • Sullivan, R.M., et al. Lateralized sex differences in stress-induced dopamine release in the rat. Neuroreport, 2009, 20(3):229-32. http://www.ncbi.nlm.nih.gov/pubmed/19188862.